The survival rate of the CD22-/- group was much lower than the control group (p<0.001), with 100% of the CD22-deficient mice reaching the experimental endpoint by 72h post-infection, whereas 56% of the control mice survived to the end of the experiment, at 168h (Fig 3A). This evidence concerns the gene CD22 and infection.